Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Reiterates Overweight on Inspire Medical Systems, Lowers Price Target to $135

Author: Benzinga Newsdesk | November 04, 2025 11:43am
Piper Sandler analyst Adam Maeder reiterates Inspire Medical Systems (NYSE:INSP) with a Overweight and lowers the price target from $150 to $135.

Posted In: INSP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist